Explore daily insights on
Marksans Pharma surges 15.7% on 21x volume spike as Q4 results announced
- Indian drugmaker Marksans Pharma surged on Tuesday as strong Q4 results were announced.
- The stock jumped 15.7% to 254.79 INR on volume of 38.06 million shares, representing 21 times the previous session's volume.
- Q4 net profit rose 63.6% YoY, with the company reporting record FY26 revenue of ₹3,033 crore.
Supporting datasets
Supporting queries
To surface this insight, Baselight ran 3 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
MARKSANS.NS rose 15.7% from 220.26 to 254.79 INR on May 26. Volume was 38,057,110 shares vs 1,813,420 the previous day and a 2,669,648 20-day average. On the same day, the company's board approved Q4FY26 audited results showing consolidated net profit of ₹148.12 crore, up 63.60% YoY, and FY26 total income of ₹3,033 crore.